Pilot Study in Patients With Symptomatic Steroid-Naive Asthma

NCT00024544 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: anti-IL-4 monoclonal antibody (pascolizumab)

Sponsor

Facet Biotech